Literature DB >> 27412619

Wheelchair use and lipophilic statin medications may influence bone loss in chronic spinal cord injury: findings from the FRASCI-bone loss study.

L R Morse1,2, N Nguyen3, R A Battaglino4, A J Guarino5, D R Gagnon6, R Zafonte3,7, E Garshick8,9.   

Abstract

We identified a protective bone effect at the knee with lipophilic statin use in individuals with chronic spinal cord injury. Lipophilic statin users gained bone at the knee compared to non-users and wheelchair users lost bone compared to walkers. Ambulation and or statins may be effective osteogenic interventions in chronic spinal cord injury (SCI).
INTRODUCTION: SCI increases the risk of osteoporosis and low-impact fractures, particularly at the knee. However, during the chronic phase of SCI, the natural history and factors associated with longitudinal change in bone density remain poorly characterized. In this study, we prospectively assessed factors associated with change in bone density over a mean of 21 months in 152 men and women with chronic SCI.
METHODS: A mixed model procedure with repeated measures was used to assess predictors of change in bone mineral density (PROC MIXED) at the distal femur and proximal tibia. Factors with a p value of <0.10 in the univariate mixed models, as well as factors that were deemed clinically significant (gender, age, and walking status), were assessed in multivariable models. Factors with a p value of ≤0.05 were included in the final model.
RESULTS: We found no association between bone loss and traditional osteoporosis risk factors, including age, gender, body composition, or vitamin D level or status (normal or deficient). In both crude and fully adjusted models, wheelchair users lost bone compared to walkers. Similarly, statin users gained bone compared to nonusers.
CONCLUSIONS: The statin finding is supported by reports in the general population where statin use has been associated with a reduction in bone loss and fracture risk. Our results suggest that both walking and statins may be effective osteogenic therapies to mitigate bone loss and prevent osteoporosis in chronic SCI. Our findings also suggest that loss of mechanical loading and/or neuronal factors contribute more to disuse osteoporosis than traditional osteoporosis risk factors.

Entities:  

Keywords:  Osteoporosis; Rehabilitation medicine; Spinal cord injury; Statin

Mesh:

Substances:

Year:  2016        PMID: 27412619      PMCID: PMC5433519          DOI: 10.1007/s00198-016-3678-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  42 in total

1.  Adiponectin is associated with bone strength and fracture history in paralyzed men with spinal cord injury.

Authors:  C O Tan; R A Battaglino; A L Doherty; R Gupta; A A Lazzari; E Garshick; R Zafonte; L R Morse
Journal:  Osteoporos Int       Date:  2014-07-01       Impact factor: 4.507

Review 2.  Statin use and fracture risk: can we quantify the healthy-user effect?

Authors:  Lawrence C McCandless
Journal:  Epidemiology       Date:  2013-09       Impact factor: 4.822

3.  Effects of statins on bone mineral density: a meta-analysis of clinical studies.

Authors:  Bernard Uzzan; Régis Cohen; Patrick Nicolas; Michel Cucherat; Gérard-Yves Perret
Journal:  Bone       Date:  2007-03-01       Impact factor: 4.398

4.  Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study.

Authors:  Julie A Pasco; Mark A Kotowicz; Margaret J Henry; Kerrie M Sanders; Geoffrey C Nicholson
Journal:  Arch Intern Med       Date:  2002-03-11

5.  Statin use and risk of Parkinson's disease: A meta-analysis.

Authors:  Zhiguo Sheng; Xiaobo Jia; Meini Kang
Journal:  Behav Brain Res       Date:  2016-04-27       Impact factor: 3.332

6.  Fracture rates and risk factors for fractures in patients with spinal cord injury.

Authors:  P Vestergaard; K Krogh; L Rejnmark; L Mosekilde
Journal:  Spinal Cord       Date:  1998-11       Impact factor: 2.772

7.  Dual energy x-ray absorptiometry of the distal femur may be more reliable than the proximal tibia in spinal cord injury.

Authors:  Leslie R Morse; Antonio A Lazzari; Ricardo Battaglino; Kelly L Stolzmann; Kirby R Matthess; David R Gagnon; Samuel A Davis; Eric Garshick
Journal:  Arch Phys Med Rehabil       Date:  2009-05       Impact factor: 3.966

8.  Statin use and lipid profile in relation to safety and functional outcome after thrombolysis in ischemic stroke.

Authors:  Irene Miedema; Maarten Uyttenboogaart; Gert-Jan Luijckx
Journal:  Expert Rev Neurother       Date:  2012-08       Impact factor: 4.618

9.  Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.

Authors:  Lars Rejnmark; Niels Henrik Buus; Peter Vestergaard; Lene Heickendorff; Frederik Andreasen; Mogens Lytken Larsen; Leif Mosekilde
Journal:  J Bone Miner Res       Date:  2004-02-16       Impact factor: 6.741

10.  Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury.

Authors:  Ashley L Doherty; Ricardo A Battaglino; Jayne Donovan; David Gagnon; Antonio A Lazzari; Eric Garshick; Ross Zafonte; Leslie R Morse
Journal:  J Bone Miner Res       Date:  2014-01       Impact factor: 6.741

View more
  9 in total

1.  STATINS AND BONE HEALTH: A MINI REVIEW.

Authors:  Leslie R Morse; Jennifer Coker; Ricardo A Battaglino
Journal:  Actual osteol       Date:  2018 Jan-Apr

Review 2.  Statin therapy: does sex matter?

Authors:  Stephanie S Faubion; Ekta Kapoor; Ann M Moyer; Howard N Hodis; Virginia M Miller
Journal:  Menopause       Date:  2019-12       Impact factor: 2.953

3.  Osteopenia in a Mouse Model of Spinal Cord Injury: Effects of Age, Sex and Motor Function.

Authors:  Michelle A Hook; Alyssa Falck; Ravali Dundumulla; Mabel Terminel; Rachel Cunningham; Arthur Sefiani; Kayla Callaway; Dana Gaddy; Cédric G Geoffroy
Journal:  Biology (Basel)       Date:  2022-01-26

Review 4.  A Primary Care Provider's Guide to Bone Health in Spinal Cord-Related Paralysis.

Authors:  Cristina L Sadowsky; Nina Mingioni; Joseph Zinski
Journal:  Top Spinal Cord Inj Rehabil       Date:  2020

5.  Prevention and management of osteoporosis and osteoporotic fractures in persons with a spinal cord injury or disorder: A systematic scoping review.

Authors:  Nour Zleik; Frances Weaver; Robert L Harmon; Brian Le; Reshmitha Radhakrishnan; Wanda D Jirau-Rosaly; B Catharine Craven; Mattie Raiford; Jennifer N Hill; Bella Etingen; Marylou Guihan; Michael H Heggeness; Cara Ray; Laura Carbone
Journal:  J Spinal Cord Med       Date:  2018-05-10       Impact factor: 1.985

6.  Ibuprofen use is associated with reduced C-reactive protein and interleukin-6 levels in chronic spinal cord injury.

Authors:  Andrew Park; Dustin Anderson; Ricardo A Battaglino; Nguyen Nguyen; Leslie R Morse
Journal:  J Spinal Cord Med       Date:  2020-06-04       Impact factor: 1.985

7.  Drug discovery in spinal cord injury-induced osteoporosis: a text mining-based study.

Authors:  Chenfeng Wang; Yang Xu; Lin Han; Weiqing Wu; Xuhua Lu
Journal:  Ann Transl Med       Date:  2022-07

8.  Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study.

Authors:  Tsung-Kun Lin; Pesus Chou; Ching-Heng Lin; Yi-Jen Hung; Gwo-Ping Jong
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

9.  Effects of FES-Rowing Exercise on the Time-Dependent Changes in Bone Microarchitecture After Spinal Cord Injury: A Cross-Sectional Investigation.

Authors:  Adina E Draghici; J Andrew Taylor; Mary L Bouxsein; Sandra J Shefelbine
Journal:  JBMR Plus       Date:  2019-09-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.